145 related articles for article (PubMed ID: 23404404)
1. Discussion of modifying stage IV gastric cancer based on Borrmann classification.
Yang B; Wu G; Wang X; Zhang X
Tumour Biol; 2013 Jun; 34(3):1485-91. PubMed ID: 23404404
[TBL] [Abstract][Full Text] [Related]
2. Borrmann type IV: an independent prognostic factor for survival in gastric cancer.
An JY; Kang TH; Choi MG; Noh JH; Sohn TS; Kim S
J Gastrointest Surg; 2008 Aug; 12(8):1364-9. PubMed ID: 18516653
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D; Xu H; Huang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
[TBL] [Abstract][Full Text] [Related]
4. [Study on the clinicopathologic characteristics and prognostic difference of gastric stump cancer between non-anastomotic site and anastomotic site].
Chen L; Wei S; Ye Z; Wang Y; Zheng Q; Zhuo C; Xiao J; Zeng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):67-72. PubMed ID: 28105623
[TBL] [Abstract][Full Text] [Related]
5. Borrmann type IV gastric cancer should be classified as pT4b disease.
Huang JY; Wang ZN; Lu CY; Miao ZF; Zhu Z; Song YX; Xu HM; Xu YY
J Surg Res; 2016 Jun; 203(2):258-67. PubMed ID: 27363630
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of Borrmann classification on advanced gastric cancer: a retrospective cohort from a single institution in western China.
Song XH; Zhang WH; Kai-Liu ; Chen XL; Zhao LY; Chen XZ; Kun-Yang ; Zhou ZG; Hu JK
World J Surg Oncol; 2020 Aug; 18(1):204. PubMed ID: 32792016
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of clinicopathological characteristics and prognosis on 42 patients with primary gastric adenosquamous cell carcinoma].
Li B; Sun L; Wang X; Deng J; Ding X; Wang X; Ke B; Zhang L; Zhang R; Liang H
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):207-212. PubMed ID: 28226357
[TBL] [Abstract][Full Text] [Related]
8. [Surgical treatment and prognosis of Borrmann type IIII( gastric cancer involving the whole stomach].
Dong R; Zhang Z; Zhou Y; Hua Y; Guo J
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):185-189. PubMed ID: 29492918
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological features and prognosis of Borrmann type IV gastric cancer.
Zhu YL; Yang L; Sui ZQ; Liu L; Du JF
J BUON; 2016; 21(6):1471-1475. PubMed ID: 28039710
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathologic features and prognostic analyses of Borrmann type IV gastric cancer].
Ma JP; Chen JH; Cai SR; Chen CQ; Yang DJ; Wu H; He YL; Zhan WH
Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(36):2534-7. PubMed ID: 23158792
[TBL] [Abstract][Full Text] [Related]
11. Peritoneal carcinomatosis and lymph node metastasis are prognostic indicators in patients with Borrmann type IV gastric carcinoma.
Chen CY; Wu CW; Lo SS; Hsieh MC; Lui WY; Shen KH
Hepatogastroenterology; 2002; 49(45):874-7. PubMed ID: 12064011
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for patients after curative resection for proximal gastric cancer.
Zhao D; Xu H; Li K; Sun Z
J Huazhong Univ Sci Technolog Med Sci; 2010 Aug; 30(4):530-5. PubMed ID: 20714884
[TBL] [Abstract][Full Text] [Related]
13. Regional lymph node metastasis as a predictor of peritoneal carcinomatosis in patients with Borrmann type IV gastric carcinoma.
Otsuji E; Yamaguchi T; Sawai K; Sakakura C; Okamoto K; Takahashi T
Am J Gastroenterol; 1999 Feb; 94(2):434-7. PubMed ID: 10022642
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and prognostic features of Borrmann type IV gastric cancer versus other Borrmann types: A unique role of signet ring cell carcinoma.
Liang C; Liang Y; Ou B; Yuan L; Yuan S
Saudi J Gastroenterol; 2023; 29(4):240-250. PubMed ID: 37470667
[TBL] [Abstract][Full Text] [Related]
15. [Rationality of N3 classification and its sub-classification in TNM classification system for advanced gastric cancer].
Cheng Y; Huang J; Zhu Z; Xu H
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jul; 19(7):749-55. PubMed ID: 27452751
[TBL] [Abstract][Full Text] [Related]
16. Macroscopic Borrmann type as a simple prognostic indicator in patients with advanced gastric cancer.
Li C; Oh SJ; Kim S; Hyung WJ; Yan M; Zhu ZG; Noh SH
Oncology; 2009; 77(3-4):197-204. PubMed ID: 19729977
[TBL] [Abstract][Full Text] [Related]
17. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
18. [Clinical value of superior mesenteric vein (No.14v) lymph node dissection in D2 gastrectomy for locally advanced distal gastric cancer].
Lu W; Zeng X; Li N; Liu H
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1136-1141. PubMed ID: 30370512
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological features of patients with Borrmann type IV gastric carcinoma.
Kim DY; Kim HR; Kim YJ; Kim S
ANZ J Surg; 2002 Oct; 72(10):739-42. PubMed ID: 12534387
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of long-term results of radical gastrectomy combining splenectomy for gastric cancer].
Han FH; Zhan WH; Li YM; He YL; Peng JS; Ma JP; Wang Z; Chen ZX; Zheng ZQ; Wang JP; Huang YH; Dong WG
Zhonghua Wai Ke Za Zhi; 2005 Sep; 43(17):1114-7. PubMed ID: 16194307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
